What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Explore very high cash back cards that come with no annual fee. Maximize your earnings effortlessly.
26,557 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A sharp rise in foreclosure activity points to growing distress and new chances for investors. Learn what the foreclo...
Institutional investors are quietly reshaping the landscape of net-lease REITs. A notable stake in Agree Realty signa...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...
Investors are weighing a shift from high-growth tech to more income-driven energy plays as AI-era capex creates uncer...
Step into the 2026 beauty health (skin) investing landscape. This guide translates early 2026 earnings signals into a...
3D Systems' Q1 2026 update sheds light on demand, margins, and cash flow across its printing systems, materials, and ...
Emcor Group combines breadth in facilities management and electrical/mechanical contracting with a steady financial p...
Rivian shocks investors by cutting jobs shortly after starting to deliver the R2. This move raises questions about ho...
June 2026 looked like a milestone month for Oklo, but the stock went the other way. This deep dive explains why the s...
A tech titan signals tighter AI budgets, nudging AI stock investors to rethink risk and opportunity. This guide break...
Investors are buzzing about SpaceX going public and what the first earnings report might reveal. Here are four core a...